Zobrazeno 1 - 10
of 83
pro vyhledávání: '"C Teres"'
Autor:
Martijn H. van der Ree, Claudia Herrera Siklody, Mathieu Le Bloa, Patrizio Pascale, Alessandra P. Porretta, Cheryl C. Teres, Jorge Solana Munoz, Adrian Luca, Giulia Domenichini, Mahmut Ozasahin, Raphael Jumeau, Pieter G. Postema, Camillo Ribi, Jean Bourhis, Luis Schiappacasse, Etienne Pruvot
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundCardiac sarcoidosis is associated with heart failure, conduction abnormalities, and life-threatening arrhythmias including ventricular tachycardia (VT). Radiotherapy has been suggested as a treatment for extra-cardiac sarcoidosis in patient
Externí odkaz:
https://doaj.org/article/5b4506c287d747a1841f59ce80ce2e34
Autor:
C. Herrera Siklody, E. Pruvot, P. Pascale, R. Kinj, R. Jumeau, M. Le Bloa, C. Teres, G. Domenichini, A.P. Porretta, M. Ozsahin, J. Bourhis, L. Schiappacasse
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 37, Iss , Pp 89-93 (2022)
Purpose: Stereotactic arrhythmia radioablation (STAR) is an effective treatment for refractory ventricular tachycardia (VT), but recurrences after STAR were recently published. Herein, we report two cases of successful re-irradiation of the arrhythmo
Externí odkaz:
https://doaj.org/article/b684be06be5c439b95bfc46193372ea9
Autor:
C Herrera Siklody, L Schiappacasse, R Jumeau, T Reichlin, A Saguner, N Andratschke, O Elicin, B Kovacs, M Mayinger, A Huber, M Le Bloa, C Teres Castillo, G Domenichini, J Bourhis, E Pruvot
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): The project is part of the STOPSTORM.eu consortium and has partially received funding from the European Union’s horizon 2020 research and inno
Autor:
J Alderete, D Penela, D Soto-Iglesias, J Marti-Almor, G Falasconi, C Teres, D Viveros, A Bellido, P Franco, C Scherer, P Francia, A Ordonez, M Huguet, J Ortiz-Perez, A Berruezo
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background Left atrial flutters (LAFL) are typically observed in patients with previous ablation lines or surgery in the left atrium (LA). Less frequently, scar-related left atrial anterior wall
Autor:
G Domenichini, D Graf, M Le Bloa, C Teres Castillo, P Carroz, C Herrera-Siklody, A P Porretta, P Pascale, E Pruvot
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): BIOTRONIK SE & Co. KG Background Published data on commercially available implantable cardiac monitors (ICMs) and the influence of body mas
Autor:
G Falasconi, D Penela, D Soto-Iglesias, C Teres, A Chauca, J Marti-Almor, J Alderete, J Meca-Santamaria, P Franco, A Ordonez, D Viveros, A Bellido, P Francia, J T Ortiz-Perez, A Berruezo
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background Pulmonary vein isolation (PVI) has proven to be effective in treating persistent atrial fibrillation (PeAF), although long-term ablation outcomes have been significantly less favorabl
Autor:
C Teres, C Haddad, M Pagnoni, M Le Bloa, C Herrera-Siklody, G Domenichini, A Porretta, E Pruvot, P Pascale
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Introduction identification of patients with new-onset conduction disturbances at risk of AV-block remains a major unmet challenge in Transcatheter Aortic Valve Replacement (TAVR). His-Ventricul
Autor:
J Solana Munoz, C Teres, A Luca, C Herrera-Siklody, H Leupi, G Domenichini, P Pascale, E Pruvot, M Le Bloa
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Other. Main funding source(s): CGRA: CARD; CGRB: 31’297 Background Pulmonary vein isolation (PVI) by cryoballoon ablation is a well-known therapy for the treatment of atrial fibrillation (AF). Curre
Autor:
Y Prudat, A Luca, N Derval, P Jais, L Roten, R Kobza, B Berte, M Le Bloa, C Herrera-Siklody, C Teres, E Pruvot, J M Vesin, P Pascale
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Swiss National Science Foundation Background Pulmonary vein isolation (PVI) is the cornerstone interventional treatment for AF. While
Autor:
J Alderete, C Teres, D Penela, D Soto-Iglesias, J Marti-Almor, G Falasconi, D Viveros, A Bellido, P Franco, C Scherer, P Francia, A Ordonez, M Huguet, J Ortiz-Perez, A Berruezo
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background Personalized pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF), tailoring the ablation index (AI) to the left atrial wall thickness (LAWT), has proven to be a hi